Seattle Genetics: Good News On The Horizon?Barron’sSeattle’s stock price fell 3% to $62.57 in recent market action after earlier dropping as much as 11% to an intraday low of $57.40 a share after the drug maker discontinued late-stage trials of an experimental leukemia drug after an independent data … …read more Source:: Seattle News By […]
from WordPress http://ift.tt/2tlpfAF
via IFTTT
3 weeks ago
No comments:
Post a Comment